ArticleThe Lancet. Planetary health2022
Ecological and socioeconomic factors associated with the human burden of environmentally mediated pathogens: a global analysis.
Article in The Lancet. Planetary health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.
- Pooled it
- Article
- Antimicrobial Agents in Fibrous Materials: A Comprehensive Review of Natural, Inorganic, and Organic Systems.Materials (Basel, Switzerland) · 2026Review
- Public health impact of nuisance biting blackfly (Simulium damnosum s.l.) along the Asejire dam in Southwest, Nigeria.BMC public health · 2026Article
- Ecological and socioeconomic factors associated with globally reported tick-borne viruses.Communications medicine · 2026Article
- Efficacy of two rounds of albendazole treatment on soil-transmitted helminths in schoolchildren, Yunnan Province, China.Nature communications · 2026Article
- Influence of natural and anthropogenic drivers on plague risk in Southwest China: A multicenter cross-sectional study.One health (Amsterdam, Netherlands) · 2025Article
- Article
- Anthropogenic activity and climate change exacerbate the spread of pathogenic bacteria in the environment.Science advances · 2025Article
- Pathogens and planetary change.Nature reviews. Biodiversity · 2025Article
- Wildlife policy, the food system and One Health: a complex systems analysis of unintended consequences for the prevention of emerging zoonoses in China, the Democratic Republic of the Congo and the Philippines.BMJ global health · 2025Article
- Introduction of Vector-Borne Infections in Europe: Emerging and Re-Emerging Viral Pathogens with Potential Impact on One Health.Pathogens (Basel, Switzerland) · 2025Review
- Local tree cover predicts mosquito species richness and disease vector presence in a tropical countryside landscape.Landscape ecology · 2025Article
- Healthy homes: Stakeholder perspectives on housing interventions to reduce environmentally mediated infections.PLOS global public health · 2025Article
- Current water contact and Schistosoma mansoni infection have distinct determinants: a data-driven population-based study in rural Uganda.Nature communications · 2024Article
- Knowledge, attitude, and practices of veterinarians towards canine vector-borne pathogens in Sri Lanka.PLoS neglected tropical diseases · 2024Article
- Epidemiology of 369 diseases and injuries attributable to 84 risk factors: 1990-2019 with 2040 projection.iScience · 2024Article
- The relationship between neighborhood economic deprivation and community-acquired pneumonia related admissions in Maryland.Frontiers in public health · 2024Article
- Surveillance and response strategies for zoonotic diseases: a comprehensive review.Science in One Health · 2023Review
- Ecological and socioeconomic factors associated with the human burden of environmentally mediated pathogens: a global analysis.The Lancet. Planetary health · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors at 8 institutions in 3 countries.
Funding
Abstract
backgroundBillions of people living in poverty are at risk of environmentally mediated infectious diseases-that is, pathogens with environmental reservoirs that affect disease persistence and control and where environmental control of pathogens can reduce human risk. The complex ecology of these diseases creates a global health problem not easily solved with medical treatment alone.
methodsWe quantified the current global disease burden caused by environmentally mediated infectious diseases and used a structural equation model to explore environmental and socioeconomic factors associated with the human burden of environmentally mediated pathogens across all countries.
findingsWe found that around 80% (455 of 560) of WHO-tracked pathogen species known to infect humans are environmentally mediated, causing about 40% (129 488 of 359 341 disability-adjusted life years) of contemporary infectious disease burden (global loss of 130 million years of healthy life annually). The majority of this environmentally mediated disease burden occurs in tropical countries, and the poorest countries carry the highest burdens across all latitudes. We found weak associations between disease burden and biodiversity or agricultural land use at the global scale. In contrast, the proportion of people with rural poor livelihoods in a country was a strong proximate indicator of environmentally mediated infectious disease burden. Political stability and wealth were associated with improved sanitation, better health care, and lower proportions of rural poverty, indirectly resulting in lower burdens of environmentally mediated infections. Rarely, environmentally mediated pathogens can evolve into global pandemics (eg, HIV, COVID-19) affecting even the wealthiest communities.
interpretationThe high and uneven burden of environmentally mediated infections highlights the need for innovative social and ecological interventions to complement biomedical advances in the pursuit of global health and sustainability goals.
fundingBill & Melinda Gates Foundation, National Institutes of Health, National Science Foundation, Alfred P. Sloan Foundation, National Institute for Mathematical and Biological Synthesis, Stanford University, and the US Defense Advanced Research Projects Agency.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.